These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8168200)

  • 41. Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging.
    Ladd J; Taylor AD; Piliarik M; Homola J; Jiang S
    Anal Bioanal Chem; 2009 Feb; 393(4):1157-63. PubMed ID: 18958451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular markers in penile cancer.
    Rodney S; Feber A; Arya M; Muneer A
    Curr Probl Cancer; 2015; 39(3):137-45. PubMed ID: 26076980
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumor Marker Ordering: Do Not Lose Control: A Prospective Clinical Trial.
    Ferraro S; Mozzi R; Panteghini M
    Am J Clin Pathol; 2015 Oct; 144(4):649-58. PubMed ID: 26386087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The riddle of protein diagnostics: future bleak or bright?
    Anderson NL; Ptolemy AS; Rifai N
    Clin Chem; 2013 Jan; 59(1):194-7. PubMed ID: 23150058
    [No Abstract]   [Full Text] [Related]  

  • 45. Development of biomarker positivity analysis system for cancer diagnosis based on clinical data.
    Yun JM; Hwang SJ; Anh SY; Lee SM; Kang P; Lee JE; Yoon ES; Choi JW; Park SH; Seo JW; Park P
    Biomed Mater Eng; 2015; 26 Suppl 1():S2101-11. PubMed ID: 26405989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tumor markers: recent advances and its future trends].
    Si LS
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):261-3. PubMed ID: 7874755
    [No Abstract]   [Full Text] [Related]  

  • 47. [Neuroendocrine markers in lung cancer].
    Shen L
    Zhonghua Bing Li Xue Za Zhi; 1993 Aug; 22(4):201-3. PubMed ID: 8168175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue culture-based breast cancer biomarker discovery platform.
    Kulasingam V; Diamandis EP
    Int J Cancer; 2008 Nov; 123(9):2007-12. PubMed ID: 18712711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.
    Takada Y; Tohyama T; Watanabe J
    J Hepatobiliary Pancreat Sci; 2015 Apr; 22(4):279-86. PubMed ID: 25408520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soft tissue tumor pathology: New diagnostic immunohistochemical markers.
    Doyle LA
    Semin Diagn Pathol; 2015 Sep; 32(5):370-80. PubMed ID: 25726492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of the distribution sites and diagnostic significance of three antibodies as the melanoma markers].
    Ji XL; Li WH
    Zhonghua Bing Li Xue Za Zhi; 1990 Jun; 19(2):128-9. PubMed ID: 2390791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment.
    Zapardiel I; Rajaram S; Piovano E; Petrillo M
    Biomed Res Int; 2015; 2015():787080. PubMed ID: 26185763
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessment of DNA Integrity, Applications for Cancer Research.
    Zonta E; Nizard P; Taly V
    Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of molecular biology in detection and monitoring of prostate cancer.
    Zummerová A; Böhmer D; Fillo J; Danihel L; Repiská V
    Cesk Patol; 2010 Oct; 46(4):95-7. PubMed ID: 21309265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomarker discovery in ovarian cancer.
    Tung CS; Wong KK; Mok SC
    Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of CEA as a marker of cancer and its surrounding tissue in 145 cases of lung carcinoma].
    Jia XS
    Zhonghua Bing Li Xue Za Zhi; 1988 Sep; 17(3):173-5. PubMed ID: 2852548
    [No Abstract]   [Full Text] [Related]  

  • 57. Challenges of Clinical Research on Hepatocellular Carcinoma.
    Kudo M; Kitano M; Sakurai T; Nishida N
    Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of prognostic factors in thymic malignancies.
    Detterbeck F; Youssef S; Ruffini E; Okumura M
    J Thorac Oncol; 2011 Jul; 6(7 Suppl 3):S1698-704. PubMed ID: 21847050
    [No Abstract]   [Full Text] [Related]  

  • 59. Issue Highlight 2015.
    Lanza F
    Cytometry B Clin Cytom; 2015; 88(5):283-5. PubMed ID: 26226829
    [No Abstract]   [Full Text] [Related]  

  • 60. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.
    Lwaleed BA; Francis JL; Chisholm M
    J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.